Ditchcarbon
  • Contact
  1. Organizations
  2. Progenics Pharmaceuticals, Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
US
updated a month ago

Progenics Pharmaceuticals, Inc.

Company website

Progenics Pharmaceuticals, Inc., a leading biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for cancer and other serious conditions. Founded in 1986, Progenics has made significant strides in the oncology sector, particularly with its pioneering work in radiopharmaceuticals and targeted therapies. The company is renowned for its flagship products, including the prostate cancer treatment, Azedra, which showcases Progenics' commitment to addressing unmet medical needs through unique therapeutic approaches. With a strong emphasis on research and development, Progenics has established a notable market position, recognised for its contributions to improving patient outcomes in oncology. As it continues to expand its portfolio, Progenics remains dedicated to advancing the field of cancer treatment and enhancing the quality of life for patients worldwide.

DitchCarbon Score

How does Progenics Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Progenics Pharmaceuticals, Inc.'s score of 25 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

44%

Let us know if this data was useful to you

Progenics Pharmaceuticals, Inc.'s reported carbon emissions

Progenics Pharmaceuticals, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. As a current subsidiary of Lantheus Holdings, Inc., any emissions data would be inherited from this parent company. However, there are no documented reduction targets or climate pledges from Progenics Pharmaceuticals, Inc. at this time. The absence of specific emissions figures and reduction initiatives highlights a potential area for improvement in their climate commitments. As the pharmaceutical industry increasingly focuses on sustainability, Progenics may benefit from establishing clear targets and strategies to reduce their carbon footprint in alignment with industry standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Progenics Pharmaceuticals, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Progenics Pharmaceuticals, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Progenics Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Mallinckrodt plc

IE
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Synergy Health Limited

GB
•
Health and social work services (85)
Updated 24 days ago

Cubist Pharmaceuticals LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

BioDelivery Sciences International, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251008.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy